artesunic acid has been researched along with Leukemia, Myelogenous, Chronic, BCR-ABL Positive in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahn, KS; Kim, C; Kim, SH; Lee, JH; Sethi, G | 1 |
1 other study(ies) available for artesunic acid and Leukemia, Myelogenous, Chronic, BCR-ABL Positive
| Article | Year |
|---|---|
Artesunate suppresses tumor growth and induces apoptosis through the modulation of multiple oncogenic cascades in a chronic myeloid leukemia xenograft mouse model.
Topics: Animals; Antimalarials; Antineoplastic Agents; Apoptosis; Artemisinins; Artesunate; Cell Growth Processes; Cell Line, Tumor; Female; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; MCF-7 Cells; Mice; Mice, Nude; Random Allocation; Xenograft Model Antitumor Assays | 2015 |